$20.96 -0.12 (-0.57%)
11/25/2009 4:00 PM

Meridian Bioscience, Inc. (VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Results 1 - 20 of 61 1 2 3 4 Next »

Recs

0
Member Avatar Relic666 (68.67) Submitted: 11/17/2009 7:54:11 AM : Underperform Start Price: $22.32 VIVO Score: +6.49

With the upcoming vote on the "health reform plan", anybody that has anything to do with the health industries will suffer.

Recs

0
Member Avatar geomanpa (< 20) Submitted: 8/24/2009 9:59:51 PM : Outperform Start Price: $23.83 VIVO Score: -20.35

Awesome management

Recs

0
Member Avatar jemsa (82.86) Submitted: 8/20/2009 3:34:25 PM : Outperform Start Price: $23.43 VIVO Score: -21.30

stockscouter 10, caps 5

Recs

0
Member Avatar vgaymer (72.39) Submitted: 4/12/2009 4:55:58 PM : Outperform Start Price: $17.20 VIVO Score: -10.68

msn screen:

5 year div. growth >= 20 %
annual eps growth >= 25%
debt/eq <= 0.5
current dividend >= 2.5%

Recs

0
Member Avatar Money4e (44.65) Submitted: 3/20/2009 7:47:01 AM : Outperform Start Price: $17.21 VIVO Score: -21.10

Rapid testing products for medical conditions. Help keep malpractice rates down and is becoming cheaper. Get's the patient tested for certain illnesses quickly which means earlier treatment, which means cheaper for the medical company

Recs

2
Member Avatar DODEA (69.18) Submitted: 12/29/2008 11:53:02 AM : Outperform Start Price: $15.19 VIVO Score: +54.58

Meridian Biosciences has been a great pick for me since 1989. It was one of the very first stocks I owned, and my second DRIP. It has very strong financials, an intelligent business plan, and many products in its pipeline. This is an excellent small-cap stock for getting in on the ground floor.

Recs

0
Member Avatar WilliamCrook2007 (< 20) Submitted: 11/20/2008 2:47:04 PM : Outperform Start Price: $22.38 VIVO Score: -51.03

ibd

Recs

0
Member Avatar moof77 (< 20) Submitted: 11/11/2008 3:22:24 AM : Outperform Start Price: $22.36 VIVO Score: -32.04

Well managed company whose products will only see more demand in coming years.

Recs

0
Member Avatar CKENNED2 (< 20) Submitted: 9/24/2008 11:20:43 PM : Outperform Start Price: $27.36 VIVO Score: -19.01

MERIDIAN IS POISED TO GAIN NEW BUSINESS UNFORTOLD

Recs

0
Member Avatar diva27 (< 20) Submitted: 9/17/2008 9:19:31 AM : Outperform Start Price: $26.01 VIVO Score: -15.44

Vivo's services are always going to be necessary, the world is not exactly getting healthier and healthier. They presently have good numbers and have shown some growth in the past. I'm confident that this is one of those stocks to watch.

Recs

0
Member Avatar hiBo (86.03) Submitted: 6/16/2008 12:51:01 AM : Outperform Start Price: $29.28 VIVO Score: -13.15

excellent financials. high percentage of insider ownership

Recs

0
Member Avatar garyedd (56.56) Submitted: 5/28/2008 9:37:29 PM : Outperform Start Price: $27.97 VIVO Score: -8.14

Boring but nasty problems in hospitals, clinics, etc will quietly drive demand. Speculative insurance against serious flu or ecoli breakouts.

Recs

1
Member Avatar healthcareinvest (50.31) Submitted: 5/5/2008 1:42:30 PM : Outperform Start Price: $26.69 VIVO Score: -3.56

Most robust point of care testing portfolio- growth not likely to slow much given the diverse lab tests available- life science sector should improve over time.

Recs

0
Member Avatar viclyn509 (31.59) Submitted: 4/24/2008 6:46:17 PM : Outperform Start Price: $26.15 VIVO Score: -2.68

No debt-Large cash flow -bright future

Recs

0
Member Avatar capsterok (< 20) Submitted: 4/24/2008 6:09:06 PM : Outperform Start Price: $32.38 VIVO Score: -21.80

Testing out a portfolio of smallish-cap 5-star stocks found using the CAPS screener. All picks have at least 50 allstars backing them, which should be enough to minimize star rating fluctuations. It's only been about a week, and I expect a LOT of volatility, but I have high hopes for market beating performance. Time will tell...

Recs

0
Member Avatar gilboy7 (< 20) Submitted: 4/19/2008 1:10:29 PM : Outperform Start Price: $25.93 VIVO Score: -2.68

oversold and undervalued after barley missing eps in qtr

Recs

2
Member Avatar Chidoc96 (< 20) Submitted: 3/25/2008 11:37:17 PM : Outperform Start Price: $29.89 VIVO Score: -15.78

Increase in visibility and spending in healthcare industry secondary to recent press about biosurveillance

Recs

2
Member Avatar 4FPRODUCECO (< 20) Submitted: 3/13/2008 9:31:41 PM : Outperform Start Price: $30.46 VIVO Score: -18.61

400% PLUS RETURN IN 3 YEARS-WHAT ELSE CAN I TELL YOU--HAS 1.5 FOR 1 SPLIT TWICE--HOW CAN IT NOT BE A FAVORITE--20% ANNUAL GROWTH RATES

Recs

2
Member Avatar juwanju (77.66) Submitted: 3/13/2008 3:04:11 PM : Outperform Start Price: $30.48 VIVO Score: -19.30

Great cash flow and great management equal great overall performance. values its shareholders and constantly progressing in the industry. GREAT VALUE!

Recs

2
Member Avatar osmosis55 (62.35) Submitted: 3/8/2008 10:10:48 PM : Outperform Start Price: $30.38 VIVO Score: -20.42

Consistently coming out with new diagnostic tests for key organisms/viruses including E.coli, H pylori, influenza, RSV. Becoming a big name in the diagnostic market and strong earnings growth likely to continue in the short-term. Late flu season this year may give earnings a boost in early 2008.

Results 1 - 20 of 61 1 2 3 4 Next »

Featured Broker Partners